Human proislet peptide, derivatives and analogs thereof, and...

Details Human proislet peptide, derivatives and analogs thereof, and... Human proislet peptide, derivatives and analogs thereof, and...

A - Human Necessities

61

K

A61K 38/17 (2006.01) A61K 38/22 (2006.01) A61K 47/48 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2726759

Human prolslet Peptides (HIP) and HIP analogs and derivatives thereof, derived from or homologous in sequence to the human REG3A protein, chromosome 2p12, are able to induce islet neogenesis from endogenous pancreatic progenitor cells. Human prolslet Peptides are used either alone or in combination with other pharmaceuticals in the treatment of type 1 and type 2 diabetes and other pathologies related to aberrant glucose, carbohydrate, and/or lipid metabolism, insulin resistance, overweight, obesity, polycystic ovarian syndrome, eating disorders and the metabolic syndrome.

Affiliated with

Also associated with

Rating

Human proislet peptide, derivatives and analogs thereof, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human proislet peptide, derivatives and analogs thereof, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human proislet peptide, derivatives and analogs thereof, and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1957911